Promising Healthcare Stocks To Consider – November 4th

Posted by on Nov 4th, 2026

Eli Lilly and Company, UnitedHealth Group, Moderna, CVS Health, and Intuitive Surgical are the five Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies involved in the healthcare industry, including pharmaceuticals, biotechnology, medical devices, healthcare services, and health insurance. Investors may view them as offering growth potential from medical innovation and demographic trends, though they can also carry risks related to regulation, drug approvals, research outcomes, and healthcare-policy changes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE LLY traded up $11.80 during mid-day trading on Wednesday, reaching $1,421.18. 1,579,815 shares of the company were exchanged, compared to its average volume of 2,940,887. Eli Lilly and Company has a 52 week low of $850.51 and a 52 week high of $1,449.68. The stock has a market capitalization of $1.34 trillion, a PE ratio of 46.22, a PEG ratio of 1.77 and a beta of 0.40. The company’s 50 day moving average price is $1,204.03 and its 200 day moving average price is $1,095.92. The company has a quick ratio of 1.00, a current ratio of 1.39 and a debt-to-equity ratio of 1.17.

Read Our Latest Research Report on LLY

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of UNH traded up $4.14 during trading hours on Wednesday, hitting $408.58. The company had a trading volume of 5,301,967 shares, compared to its average volume of 7,230,104. The firm has a market cap of $366.73 billion, a P/E ratio of 23.30, a P/E/G ratio of 1.45 and a beta of 0.51. UnitedHealth Group has a 52-week low of $255.96 and a 52-week high of $461.62. The stock’s 50 day moving average price is $390.47 and its 200 day moving average price is $363.08. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

Read Our Latest Research Report on UNH

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

Shares of Moderna stock traded up $18.19 on Wednesday, hitting $246.63. The stock had a trading volume of 7,815,954 shares, compared to its average volume of 12,603,919. The stock’s 50-day simple moving average is $185.79 and its two-hundred day simple moving average is $88.36. Moderna has a one year low of $22.28 and a one year high of $254.48. The stock has a market cap of $98.47 billion, a price-to-earnings ratio of -30.88 and a beta of 1.16. The company has a quick ratio of 2.18, a current ratio of 2.29 and a debt-to-equity ratio of 0.09.

Read Our Latest Research Report on MRNA

CVS Health (CVS)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

CVS traded down $11.46 during midday trading on Wednesday, reaching $79.95. 20,101,283 shares of the company’s stock traded hands, compared to its average volume of 8,393,045. The stock has a market capitalization of $102.26 billion, a price-to-earnings ratio of 21.15, a P/E/G ratio of 0.82 and a beta of 0.58. CVS Health has a 52 week low of $69.51 and a 52 week high of $110.68. The firm has a fifty day moving average of $91.08 and a two-hundred day moving average of $88.87. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

Read Our Latest Research Report on CVS

Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Shares of Intuitive Surgical stock traded up $43.70 during midday trading on Wednesday, reaching $484.45. 2,550,570 shares of the company’s stock traded hands, compared to its average volume of 2,434,102. The company has a market cap of $167.93 billion, a PE ratio of 58.46, a price-to-earnings-growth ratio of 3.01 and a beta of 1.45. The stock has a 50 day moving average of $404.05 and a 200-day moving average of $432.90. Intuitive Surgical has a 12 month low of $328.57 and a 12 month high of $603.88.

Read Our Latest Research Report on ISRG

Further Reading